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Abstract. Ran is a nuclear Ras-like GTPase that is re- 
quired for the bidirectional transport of proteins and ri- 
bonucleoproteins across the nuclear pore complex 
(NPC). A key regulator of the Ran GTP/GDP cycle is 
the 70:kD Ran-GTPase-activating protein RanGAP1. 
Here, we report the identification and localization of a 
novel form of RanGAP1. Using peptide sequence anal- 
ysis and specific mAbs, RanGAP1 was found to be 
modified by conjugation to a ubiquitin-like protein. 
Immunoblot analysis and immunolocalization  by light 
and EM demonstrated that the 70-kD unmodified form 
of RanGAP1 is exclusively cytoplasmic, whereas the 
90-kD modified form of RanGAP1 is associated with 
the cytoplasmic fibers of the NPC. The modified form 
of RanGAP1 also appeared to associate with the mi- 
totic spindle apparatus during mitosis. These findings 
have specific implications for Ran function and broad 
implications for protein regulation by ubiquitin-like 
modifications. Moreover, the variety and function of 
ubiquitin-like protein modifications in the cell may be 
more diverse than previously realized. 
T 
RANSPORT of macromolecules across the nuclear en- 
velope occurs bidirectionally through nuclear pore 
complexes  (NPCs) 1,  large  supramolecular  assem- 
blies that span both membranes of the nuclear envelope 
(Rout and Wente, 1994). Whereas small ions and metabo- 
lites can passively diffuse through the NPC, most proteins 
and ribonucleoproteins are transported across the NPC by 
a signal- and energy-dependent mechanism. Dissection  of 
the events culminating in nuclear import has been aided 
by the development of a permeabilized cell system that 
has made possible  the identification of soluble cytosolic 
factors required for nuclear import (Adam et al., 1990), 
and more recently by the development of solution binding 
assays that use recombinant transport factors and nucleo- 
porins (Rexach and Blobel, 1995). 
Using the permeabilized cell assay in conjunction with 
biochemical fractionation of cytosolic extracts, four factors 
required for nuclear import have been purified and char- 
acterized (Moore and Blobel,  1993, 1994; Melchior et al., 
1993; Adam and Adam, 1994; G6rlich et al., 1994, 1995; 
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Chi et al., 1995; Enenkel et al., 1995; Imamoto et al., 1995; 
Moroianu et al., 1995a; Paschal and Gerace, 1995; Radu et al., 
1995). Recognition of nuclear localization  signal  (NLS)- 
containing substrates in the cytoplasm is mediated by the 
c~ subunit of the karyopherin-cd13 heterodimer (Enenkel 
et al., 1995; Moroianu et al., 1995a; Weis et al., 1995), and 
docking of the trimeric complex to the NPC is mediated by 
the 13 subunit (Moroianu et al., 1995b; Radu et al., 1995). 
Peptide repeat-containing nucleoporins (Rout and Wente, 
1994), which bind karyopherin-13 in vitro and are compo- 
nents of the cytoplasmic and nucleoplasmic  fibers as well 
as the peripheries of the central channel, have been pro- 
posed to form an array of substrate/receptor docking sites 
(Radu et al., 1995). The small GTPase Ran and the Ran- 
interactive protein pl0 are believed to mediate the dissoci- 
ation of substrate/receptor complexes  as they dock along 
these sites (Melchior et al., 1993; Moore and Blobel, 1993, 
1994; Paschal  and Gerace, 1995). While the exact nature 
and molecular dynamics of translocation across the NPC 
remain to be elucidated, in vitro binding assays have re- 
cently revealed functional relationships among the karyo- 
pherin heterodimer, Ran, pl0, and peptide repeat-contain- 
ing nucleoporins,  pl0 binds directly to the peptide repeat- 
containing nucleoporins, Ran-GDP,  and  karyopherin-13, 
and has been proposed to coordinate substrate/receptor 
dissociation  reactions at the NPC (Nehrbass and Blobel, 
1996; Paschal et al., 1996; Matunis, M.J., G. Blobel, and M. 
Hijikata, unpublished data). Actual release of docked sub- 
strate/receptor complexes  appears to be mediated by the 
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the karyopherin heterodimer (Rexach and Blobel, 1995; 
Moroianu et al., 1996). All these findings point to Ran and 
factors regulating its guanine nucleotide state as key deter- 
minants of nucleocytoplasmic transport. 
Similar to other GTPases, Ran is presumed to function 
as  a  molecular switch,  associating with  and  dissociating 
from interacting proteins through conformational changes 
driven by GTP hydrolysis or by nucleotide exchange (Bourne 
et al., 1991; Rush et al., 1996; Sazer, 1996). The intrinsic 
rates  of hydrolysis and  exchange by Ran  are  extremely 
low, and these reactions are therefore catalyzed by regula- 
tory factors whose subcellular distributions  define Ran's 
activities. Nucleotide exchange by Ran is catalyzed by the 
GDP-GTP  exchange  factor RCC1  (Bischoff and  Pons- 
tingl, 1991), and GTP hydrolysis is catyalyzed by the GTP- 
ase-activating  protein  RanGAP1  (Bischoff et  al.,  1994, 
1995a,b). RCC1 is a nuclear chromatin-associated protein, 
initially identified as a factor involved in the control of mi- 
totic events, including chromatin condensation and cell cy- 
cle progression (Ohtsubo et al., 1987, 1989; Bischoff et al., 
1990; Dasso, 1993). RanGAP1, on the other hand, was ini- 
tially identified in Saccharornyces cerevisiae as RNAI-1, a 
mutant defective in RNA production, processing, and nu- 
clear export (Hartwell, 1967; Traglia et al.,  1989). Immu- 
nolocalization of Rnalp identified it as a cytoplasmic pro- 
tein  that  is  excluded  from  the  nucleus  (Hopper et  al., 
1990). The mammalian RanGAP1 was purified from HeLa 
cells as a  homodimer of 65-kD subunits  that specifically 
enhanced the rate of Ran-GTP hydrolysis by three orders 
of magnitude (Bischoff et al.,  1994,  1995a,b). In general, 
these  findings  imply that  Ran  is  converted to its  GTP- 
bound form in the nucleus and hydrolyzed to its  GDP- 
bound form in the cytoplasm. Two additional proteins that 
bind Ran-GTP and likely effect GTP hydrolysis are the 
cytosolic  factor  RanBP1  and  the  nucleoporin  Nup358 
(Coutavas  et al.,  1993; Wu et al.,  1995; Yokoyama et al., 
1995).  RanBP1  and  Nup358  contain  domains  that  have 
been reported to enhance  RanGAPl-induced  Ran-GTP 
hydrolysis  by  an  order  of  magnitude  (Bischoff  et  al., 
1995b; Beddow et al., 1995). The localization of Nup358 to 
the cytoplasmic fibers of the NPC suggests that an early 
step in nuclear import may involve GTP hydrolysis at or 
near these fibers. Consistent with this possibility, several 
reports have suggested  a  concentration of RanGAP1  at 
the nuclear envelope (Melchior et al., 1993; Bischoff et al., 
1994; Koepp et al., 1996). 
While  the  subcellular  distributions  of RanGAP1  and 
RCC1  seem to be strictly defined based on immunofluo- 
rescence localization and cell fractionation, it remains to 
be determined whether these factors are more precisely 
localized at the site of nuclear transport (i.e., the NPC). 
Targeting of a subpopulation of RCC1 and/or RanGAP1 
to the NPC could potentially be regulated by modification 
of these factors. One modification that specifies protein 
targeting  is  ubiquitination,  which  is  a  posttranslational 
modification involving the  covalent  ligation  of the  car- 
boxyl terminus of ubiquitin to internal lysine residues in a 
host of intracellular proteins (Hershko and Ciechanover, 
1992; Wilkinson, 1995). Whereas the primary fate of ubiq- 
uitinated proteins is degradation by the 26S proteosome 
(Ciechanover, 1994; Jentsch and Schlenker, 1995), it has 
long been recognized that ubiquitination is likely to have 
roles beyond proteolysis. Ubiquitin conjugation has been 
recently shown to act as a signal for endocytosis and vacu- 
olar targeting (Egner and Kuchler, 1996; Galan et al., 1996; 
Hicke and Riezman, 1996; Roth and Davis, 1996; Strous 
et al.,  1996) and as regulator of IKB kinase activity (Chen 
et al., 1996).  In addition to functions other than proteoly- 
sis, a recurring question related to the ubiquitin system has 
been whether substrates other than ubiquitin may be used 
in parallel pathways to regulate as yet unrecognized cellu- 
lar activities. 
Here, we report the identification of a novel 90-kD form 
of the Ran-GTPase-activating protein RanGAP1. By pep- 
tide sequence analysis and using specific mAbs, the 90-kD 
RanGAP1 was identified as a modified form of the previ- 
ously described 70-kD RanGAP1. The modification was 
found to consist of a covalent ligation between RanGAP1 
and a novel ubiquitin-like protein, and it could be reversed 
by an enzymatic activity that cofractionated with the NPC. 
Moreover, the 90-kD modified form of RanGAP1 was it- 
self localized to the NPC, and more specifically, to the cy- 
toplasmic fibers of the NPC.  In contrast, the 70-kD  un- 
modified  form  of  RanGAP1  was  strictly  cytoplasmic. 
Thus, a novel ubiquitin-like modification appears to mod- 
ulate the partitioning of RanGAP1  between the  cytosol 
and the NPC. 
Materials and Methods 
Isolation and Fractionation  of Rat Liver 
Nuclear Envelopes 
Rat liver nuclei were isolated as described (Blobel and Potter, 1966)  and 
stored frozen at -80°C in 100-U aliquots (1 U = 3 ×  106 nuclei). Nuclear 
envelopes were prepared by a modification of the procedure described by 
Dwyer and Blobel (1976). Nuclei were thawed and pelleted at 500 rpm in 
a tabletop microfuge for 1 min. After removing the supernatant, the pellet 
was resuspended to a final concentration of 100 U/ml by dropwise addi- 
tion of cold buffer A  (0.1 mM MgClz, protease inhibitors [0.5 mM PMSF, 
1 ~g/ml leupeptin, 1 p,g/ml pepstatin A, and 18 ixg/ml aprotinin], 5 ~,g/ml 
DNase I  (Sigma Chemical Co., St.  Louis, MO), and 5  /.Lg/ml RNase A 
[Sigma Chemical Co., St. Louis, MO]) with constant vortexing. The nuclei 
were  then immediately diluted to  20  U/ml by the  addition  of ice-cold 
buffer B (10% sucrose, 20 mM triethanolamine, pH 8.5, 0.1 mM MgCI2, 
1 mM DTI% and protease inhibitors), again with constant vortexing. The 
suspension was dounced four times in a glass dounce homogenizer (tight 
pestle) and incubated at room temperature for 15 min. After the 15-min 
incubation, the suspension was underlaid with 5 ml of ice-cold buffer C 
(30%  sucrose, 20 mM triethanolamine, pH 7.5,  0.1  mM MgCI2,  1 mM 
DTT, and protease inhibitors) and centrifuged at 2,600 g  in a  swinging 
bucket rotor (model type HB-4; Sorvall, Wilmington, DE) for 15 rain at 
4°C. After removing the supernatant and sucrose cushion, the pellet was 
resuspended to a  final concentration of 100  U/ml in ice-cold buffer D 
(10%  sucrose, 20 mM triethanolamine, pH 7.5,  0.1  mM MgCI2,  1 mM 
DTT, and protease inhibitors). The suspension was dounced as described 
above, and diluted to 66 U/ml by the addition of cold buffer C plus 0.3 p~g/ 
ml heparin (Sigma Chemical Co.). The suspension was immediately un- 
derlaid with 5 ml of buffer C and pelleted as described above. The pellet 
resulting from this second extraction is operationally defined as the nu- 
clear envelope fraction. The pore complex lamina fraction (PCLF) was 
derived from the nuclear envelope fraction by extraction with 1% Triton 
X-100 and 0.025% SDS, followed by an additional round of centrifugation 
as described above. 
Conditions for Empigen BB extraction of the PCLF were as follows: 
The PCLF was resuspended in cold buffer D  (minus DT'F) at 100 U/ml 
and divided into two samples, one for mock N-ethylmaleimide (NEM) 
treatment and one for NEM treatment. To the mock NEM-treated sam- 
ple, DTI" was added to a final concentration of 10 mM, and NEM (pre- 
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subsequently added  to  a  final  concentration  of 5  mM.  To  the  NEM- 
treated sample, NEM alone was added to 5 mM. Both samples were incu- 
bated on ice for 5 rain and then extracted by dilution of the samples to 66 
U/ml with buffer D  containing 0.9% Empigen BB (Calbiochem/Novabio- 
chem Corp., La JoUa, CA). Samples were incubated on ice for 5 min and 
subsequently pelleted for 15 min at 15,000  rpm. After precipitation with 
10% TCA, the samples were resuspended in sample buffer, and the equiv- 
alent of 10 U of nuclei were analyzed by immunoblot analysis. 
Preparation of  mAbs 
mAbs 19C7, 19G12, and 2F1 were prepared by immunizing BALB/c mice 
with recombinant protein (prepared as described below) consisting of the 
first 203  amino-terminal residues of mouse RanGAP1. mAb 21C7 was 
produced by immunizing mice with the full-length recombinant GMP1, 
prepared  as described below. Hybridoma production and screening and 
ascites production  were  performed  as  described  previously  (Choi  and 
Dreyfuss, 1984).  Antibody specificities were determined by immunofluo- 
rescence and immunoblot analysis. 
Gel Electrophoresis  and Immunoblot Analysis 
Proteins were separated by SDS-PAGE and transferred to a  nitrocellu- 
lose  membrane as  described  previously  (Dreyfuss et  al.,  1984).  Mem- 
branes were blocked in 5% nonfat dry milk in PBST (137 mM NaCI  2, 2.7 
mM KCI2, 1.5 mM KH2PO4, 8.1 mM Na2HPO4, 0.1% Tween 20). mAb as- 
cites fluids were diluted 1:2,000 in PBST containing 2% BSA. Antibodies 
were detected using luminol-based chemiluminescence. 
Peptide Sequence Analysis 
Rat liver nuclear envelopes were separated by SDS-PAGE (10%  acryl- 
amide) and transferred to a polyvinylidene difiuoride membrane. The 
90-kD Ran-GTP-binding protein was identified by staining with Ponceau 
S, cut from the membrane, and digested with endoproteinase Lys-C. Pep- 
tides were separated and sequenced as described (Fernandez et al., 1992). 
Immunofluorescence Microscopy 
Buffalo rat liver (BRL) cells grown on coverslips were washed in PBS and 
either fixed in 2% formaldehyde/PBS for 30 min at room temperature and 
permeabilized with -20°C acetone for 3 min, or were permeabilized with 
50 ixg/ml digitonin (Aldrich Chemical Co., Milwaukee, WI) in transport 
buffer (20 mM Hepes-KOH, pH 7.3, 110 mM potassium acetate, 2  mM 
magnesium acetate, 1 mM EGTA, 2 mM DT1  ~, and protease inhibitors) 
for 5 min at room temperature, followed by fixation in 2% formaldehyde/ 
PBS for 30 min at room temperature. Primary antibodies were diluted 
1:2,000 in 2% BSA/PBS and incubated with the fixed cells for 1 h at room 
temperature. After washing with PBS, the cells were incubated with fluo- 
rescein-conjugated goat anti-mouse (Organon/Teknika, Durham, NC) for 
30 min at room temperature, washed again in PBS, and mounted in buffer 
containing 80% glycerol, 50 mM Tris-HC1, pH 8.0, and 0.1% p-phenylene- 
diamine. 
Immunopurifications 
100 U  of rat liver nuclear envelopes in buffer D  (200 U/ml) were solubil- 
ized by addition of SDS to a final concentration of 0.5% and by heating at 
55°C for 10 min. 4 vol of RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM 
NaC1,  1%  NP-40, 0.5%  deoxycholate) were  subsequently added to  the 
sample followed by centrifugation at 20,000 g for 20 min. The supernatant 
was split into two tubes and incubated for 1 h  at 4°C with 1 p.l of mAb 
19C7 ascites fluid or with 1 p,1 of ascites fluid produced by mice injected 
with the parent myeloma cell line SP2/0. 20 p,1 of protein G-Sepharose 
(Pharmacia Biotech Inc., Piscataway, NJ) was then added and the samples 
were incubated for an additional hour at 4°C. After brief centrifugations, 
the resins were washed four times with ice-cold RIPA buffer/0.1% SDS, 
one time with PBS, and then boiled in SDS sample buffer. The equivalent 
of 20 U of nuclei were used for immunoblot analysis. 
Bacterial Expression of Recombinant Proteins 
DNA fragments encoding amino acids 1-203 of mouse RanGAP1 or the 
entire  open  reading frame  of expressed sequence tagged  (EST)  clone 
32220 (starting with the first in frame methionine) were generated by PCR 
and subcloned into the NdeI and AvaI sites of the bacterial expression 
vector pET21a  (Novagen, Inc.,  Madison,  WI).  The  expression vectors 
were transfected into the Escherichia  coli strain BL21 (DE3) pLysE, and 
recombinant proteins were induced for 3 h  at 37°C by the addition of 
0.2 mM isopropyl thio-13-o-galactoside (IPTG) to the culture media. Bac- 
teria were harvested, lysed in 6 M guanidine hydrochloride, and recombi- 
nant proteins were purified by Ni-NTA agarose as recommended by the 
manufacturer (QIAGEN  Inc., Chatsworth, CA). Purified proteins were 
TCA precipitated and resuspended in PBS. 
Immunogold EM 
Rat liver nuclear envelopes (prepared as described above) were processed 
for immunogold EM as described (Wu et al., 1995).  Envelopes were incu- 
bated with a mixture of mAbs 19C7,19G12, and 2F1, each diluted 1:1,000. 
Results 
Identification of  a 90-kD Form of  RanGAP1 Associated 
with Isolated Nuclear Envelopes 
To evaluate the role of Ran in translocation of substrates 
through  the  NPC  in  more  detail,  we  have  characterized 
proteins that are associated with the NPC and that interact 
directly with Ran-GTP. Two elements were used in identi- 
fying proteins with these credentials: (a) a subcellular frac- 
Figure 1.  Identification of a  90-kD Ran-GTP-binding  protein as- 
sociated with isolated nuclear envelopes. Rat liver nuclear enve- 
lopes  were  isolated  and  separated  by  SDS-PAGE  (10%  acryl- 
amide). Proteins were visualized by silver stain (lane 1), or were 
transferred to nitrocellulose membrane and probed with [32p]GTP- 
labeled  Ran  (lane 2), as described  (Coutavas et al., 1993).  The 
asterisk in lane I  indicates the position of the 90-kD protein iden- 
tified  in  lane 2,  and  the protein  subjected  to  peptide  sequence 
analysis. 
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assay using radiolabeled Ran-GTP. Starting with purified 
rat liver nuclei, a  highly enriched nuclear envelope frac- 
tion that contained all of the currently known nucleopor- 
ins and that was essentially free of contaminating chroma- 
tin and chromatin-associated proteins was isolated (Fig. 1, 
lane 1). When proteins in this fraction were transferred to 
a  nitrocellulose membrane and probed with radiolabeled 
Ran-GTP,  four  prominent  bands  were  detected,  corre- 
sponding to proteins with apparent molecular masses  of 
350, 250, 180, and 90 kD (Fig. 1, lane 2). The highest mo- 
lecular mass protein corresponds to the previously charac- 
terized nucleoporin, Nup358 (Wu et al., 1995; Yokoyama 
et al., 1995), while the proteins of 250 and 180 kD remain 
uncharacterized. All of the identified proteins bound spe- 
cifically to  Ran-GTP,  since  their binding  was  competed 
with excess cold Ran-GTP, but not with excess cold Ran- 
GDP (data not shown). Using this same assay, Lounsbury 
et  al.  (1994)  have identified  a  similar  subset  of nuclear 
Ran-GTP-binding proteins. 
The nuclear envelope-associated Ran-GTP-binding pro- 
tein migrating at 90 kD was recognized as a single protein 
(proteins were stained with Ponceau S and their positions 
were  marked  before incubation  with  Ran-GTP),  and  it 
was  subjected  to  peptide  sequence  analysis.  Three pep- 
tides, encompassing a total of 66 amino acids, were virtu- 
ally identical to a protein that had been characterized pre- 
viously as a Ran GTPase-activating protein and known as 
Fugl (DeGregori et al., 1994) or RanGAP1 (Bischoff et al., 
1995a) (Fig. 2 A). The peptides were derived from regions 
spanning nearly the entire 589 amino acids predicted for 
RanGAP1, ranging from amino acids 44 to 470. In addi- 
tion to the three peptides identical to RanGAP1, a fourth 
peptide sequence was obtained that showed no homology 
to the predicted amino acid sequence of RanGAP1, but 
that was  encoded by a  human EST cDNA,  clone 32220 
(Fig. 2 B). 
cDNAs  predicting  a  65-kD  RanGAP1  have been iso- 
lated from both human and mouse sources (DeGregori 
et  al.,  1994;  Bischoff et  al.,  1995).  Furthermore,  human 
RanGAP1  purified from HeLa cells migrates (after eight 
fractionation procedures) as a 65-kD polypeptide by SDS- 
PAGE (Bischoff et al., 1994). To demonstrate further that 
the protein we identified was homologous to RanGAP1, 
mAbs were generated against a recombinant protein cor- 
responding to the first 203  amino acids  encoded by the 
mouse RanGAP1 cDNA. Hybridomas producing antibod- 
ies specific for RanGAP1  were selected by immunofluo- 
rescence and  immunoblot  analysis.  All of the identified 
mAbs recognized a 90-kD protein (which on higher reso- 
lution gels appeared as three closely spaced proteins) in 
the  nuclear  envelope fraction that  comigrated  with  the 
protein detected with labeled Ran-GTP (Fig.  2  C).  Our 
identification of a 90-kD protein homologous to RanGAP1, 
as well as previous work identifying a 65-kD protein (Bisch- 
off et al., 1994), suggest the existence of two highly related 
RanGAP1  molecules. The  identification of one peptide 
with no homology to RanGAP1  suggested three possible 
origins for the 90-kD protein. These include a unique gene- 
encoding protein highly related to  RanGAP1,  an  alterna- 
tively spliced message derived from the RanGAP1 gene, or a 
posttranslational modification involving the attachment of 
an independently encoded polypeptide to RanGAP1. 
Detection of Two Forms of RanGAP1 and Their 
Localization to Distinct Subcellular Domains 










416  ILDPNSGEPAPVLSSPTPTDLSTFLSFPS 444 
IIIIIIIIIIIIIIII  IIIIIIIIIIII 
ILDPNSGEPAPVLSSPPPTDLSTFLSFPS 
RanGAP1  455  VSVLIVOQTDTSDPEK 470 
IIIIIIIIIIIIIIII 
pgO  VSVLIVQQTDTSDPEK 
EST 32220 
p90 
51  YCQRQGVPMNSLRFLFEGQ 69 
IIIIIIIIIIIIIIIIIII 
YCQRQGVPMNSLRFLFEGQ 
Figure  2.  The  90-kD  Ran- 
GTP-binding protein associ- 
ated with isolated nuclear en- 
velopes  is  homologous  to 
RanGAP1. (A) Alignment of 
peptide  sequences  derived 
from  the  90-kD  Ran-GTP- 
binding  protein  (p90)  with 
predicted  amino  acid  se- 
quences of mouse RanGAP1. 
(B)  Alignment  of a  unique 
peptide  sequence  derived 
from p90 with the predicted 
amino acid sequence derived 
from EST clone  32220. (C) 
Immunoblot  analysis of iso- 
lated  nuclear  envelope pro- 
teins  with  the  RanGAP1- 
specific mAb 19C7. 
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we used the mAbs against RanGAP1 to characterize it in 
cultured  cells.  Immunofluorescence microscopy on form- 
aldehyde-fixed and  acetone-permeabilized BRL cells re- 
vealed a  diffuse cytoplasmic signal, as well as an intense 
nuclear rim staining, further demonstrating an association 
of RanGAP1  with the nuclear envelope (Fig. 3 a). When 
cells were treated with digitonin (a detergent that specifi- 
cally permeabilizes the plasma membrane, but not the nu- 
clear envelope) before fixation, and then stained with anti- 
bodies,  the  cytoplasmic signal  was  no  longer  apparent, 
indicating  an  extraction  of  the  cytoplasmic  RanGAP1 
(Fig. 3 b). Nuclear rim staining, however, was still evident 
and its punctate appearance was very similar to that ob- 
served  with  antibodies  specific  for  nucleoporins  (Davis 
and  Blobel,  1986).  Because  the  nuclear  envelope is  not 
permeabilized by digitonin, detection of RanGAP1 under 
these conditions suggests an association with the cytoplas- 
mic side of the nuclear envelope. During mitosis, RanGAP1 
was detected throughout the cell, but surprisingly, it was 
also found associated with the mitotic spindles.  Although 
association  with  the  spindles  could  be  detected  in  cells 
fixed and  then  permeabilized (Fig.  3  a), the  localization 
was most obvious when cells were permeabilized with dig- 
itonin  before  fixation  (Fig.  3,  c-f).  By  early  telophase, 
RanGAP1  was detected  as a  halo around  the  surface of 
the newly condensed chromatin (Fig. 3 f). 
Antibodies against RanGAP1 were next used for immu- 
noblot analysis. When  total BRL cell lysate was probed 
with antibodies against RanGAP1, two proteins with ap- 
parent molecular masses of 90 and 70 kD were detected 
(Fig.  4,  lane  1),  confirming the  presence  of two  related 
forms  of  RanGAP1.  Similar  to  the  multiple  bands  de- 
tected  in  isolated  nuclear  envelopes,  the  90-kD  protein 
was  actually three  closely spaced proteins, whereas  the 
70-kD protein resolved into at least two proteins. As dem- 
onstrated above, the cytoplasmic pool of RanGAP1 is ex- 
tracted with digitonin, leaving RanGAP1 association with 
the  nuclear  envelope intact.  Immunoblot analysis of the 
digitonin-soluble and -insoluble fractions revealed a clear 
fractionation  of the  two forms of RanGAP1.  Consistent 
with data presented above on isolated nuclear envelopes, 
only the 90-kD form of RanGAP1 was detected in the dig- 
itonin-insoluble  fraction (Fig. 4,  lane 2).  Conversely, the 
70-kD form of RanGAP1  was the predominant form de- 
tected in the soluble fraction (Fig. 4, lane 3) along with a 
relatively minor amount of the 90-kD form (15% of the to- 
tal). Together, the immunoblot and immunofluorescence 
data  demonstrate  that  the  70-kD  form of RanGAP1  is 
completely  cytoplasmic,  and  that  the  90-kD  form  of 
RanGAP1  is  associated  predominantly with  the  nuclear 
envelope. 
To  localize  further  the  nuclear  envelope-associated 
90-kD  form  of  RanGAP1,  immunogold  EM  was  per- 
Figure 3.  RanGAP1 localizes to the cytoplasm and to the nuclear envelope in interphase cells, and during mitosis, it associates with the 
mitotic spindles. BRL cells were grown on coverslips, fixed, and permeabilized as indicated before incubation with mAb 19C7. (a) Inter- 
phase cells first fixed with formaldehyde and then permeabilized with acetone. The arrow indicates a metaphase ceil in which staining of 
the mitotic spindles is visible. (b) Interphase cells first permeabilized with digitonin  followed by formaldehyde fixation.  (c) A cell in 
prophase, first fixed with formaldehyde and then permeabilized with acetone.  (d) A metaphase cell first permeabilized with digitonin 
and then fixed with formaldehyde. (e) An anaphase cell first permeabilized with digitonin and then fixed with formaldehyde. (f) A cell 
in telophase, first permeabilized with digitonin and then fixed with formaldehyde. Bars: (a and b) 10 I~m;  (c-f) 8 ~m. 
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RanGAP1 are detected, and 
they fractionate with distinct 
subcellular  domains.  BRL 
cells  were  either  lysed  di- 
rectly in SDS-PAGE sample 
buffer (lane 1), or they were 
fractionated into a digitonin- 
insoluble  fraction  (lane  2) 
and a digitonin-soluble  frac- 
tion (lane 3).  Proteins  were 
separated  by  SDS-PAGE 
(12.5%  acrylamide),  trans- 
ferred to nitrocellulose mem- 
brane,  and  probed  with 
mAb 19C7. 
formed using isolated nuclear envelopes and RanGAP1- 
specific antibodies (Fig. 5). The 90-kD form of RanGAP1 
localized to the NPCs  (consistent with biochemical sub- 
fractionation; data not shown), with 95% (total = 1547) of 
the signal detected in association with cytoplasmic aspects 
of the NPC. Similar to the localization reported previously 
for Nup358 (Wu et al.,  1995; Yokoyama et al., 1995), the 
90-kD form of RanGAP1  appeared to localize at or near 
the tips of the cytoplasmic fibers of the NPC (Fig. 5 C). In 
addition to this predominant localization, 5 %  of the total 
signal was associated with the nucleoplasmic face of the 
NPC. The low level of signal was not a result of inaccessi- 
bility of the antibodies to the nucleoplasmic side of the nu- 
clear envelopes, as determined by labeling with antibodies 
to both Nup153 and the nuclear tamins (data not shown). 
The 90-kD form of RanGAP1, therefore, localizes defini- 
tively to the cytoplasmic fibers of the NPC and possibly to 
the nucleoplasmic side of the NPC. In summary, two forms 
of RanGAP1  have been identified: a 70-kD form localiz- 
ing specifically to the cytoplasm and corresponding to the 
previously characterized 65-kD RanGAP1,  and  a  90-kD 
form localizing predominantly to the cytoplasmic fibers of 
the NPC. 
Identification of a Novel Ubiquitin-like Polypeptide 
Associated with RanGAP1 
To further investigate the relationship between the 90-kD 
form of RanGAP1 and the previously characterized 65-kD 
form of RanGAP1, we focused on EST clone 32220, which 
coded for the one novel peptide sequence described above. 
The 1.5-kb cDNA clone was obtained from the IMAGE 
consortium  (Lawrence  Livermore National  Laboratory, 
Livermore, CA), and an open reading frame was identi- 
fied starting at the 5' end and extending through nucleo- 
tide 386 (Fig. 6 A). A putative initiation codon begins with 
nucleotide  100,  and surrounding nucleotides conform to 
the consensus for translation initiation (Kozak, 1991). Be- 
ginning with this methionine, the open reading frame codes 
for a protein with a predicted molecular mass of 11.5 kD. 
When expressed in bacteria, the recombinant protein mi- 
grated with an apparent molecular mass of 17 kD by SDS- 
PAGE, similar to the presumptive free form of the protein 
identified in rat liver nuclei (see Fig. 10; data not shown). 
The protein encoded by this open reading frame will be re- 
ferred to as GMP1 (GAP modifying protein 1). A  search 
of sequence data bases for proteins homologous to GMP1 
revealed a family of highly related proteins in a wide range 
of organisms, including plants  (Oryza sativa, Arabitopsis 
thaliana, and Brassica campestris), worms ( Caenorhabditis 
elegans), protozoans (Plasmodium falciparum  and  Toxo- 
plasma gondii), and fungi (S. cerevisiae). While the major- 
ity of sequences were  incomplete translations  predicted 
from EST clones, full-length open reading frames were de- 
rived from several overlapping clones (Fig. 6 B). Based on 
the  sequence  similarities  between  homologues,  GMP1 
could be divided into three domains. The amino-terminal 
domain (defined by the first 20 amino acids) varies greatly 
between homologues, while the second domain, extending 
from amino acid 20 to a carboxyl-terminal double glycine, 
is highly conserved. All of the proteins contained a third 
domain  of variable  sequence  and  length,  extending be- 
yond the carboxyl-terminal double glycine. Among mam- 
mals,  human,  mouse,  and  rat  GMP1  were  found  to  be 
100%  identical,  and  human  cDNAs  encoding two  addi- 
tional GMPl-related proteins were also identified. A  full- 
length open reading frame was deduced from one of these 
clones, and it predicts a  protein that is 45%  identical to 
GMP1  throughout  its  entire  length  and  53%  identical 
throughout its carboxyl-terminal domain (Mannen et al., 
1996).  Overall identities between GMP1  and  the worm, 
rice, and yeast homologues are 59,  39,  and 40%, respec- 
tively, whereas  identities  between  the  carboxyl-terminal 
domains are 64,  42, and 46%, respectively. Interestingly, 
the yeast homologue (Smt3p) was originally identified as a 
suppressor of MIF2, a gene encoding a centromere-associ- 
ated protein required for mitotic spindle integrity (Meluh 
and Koshland, 1995). 
The homology of most significance, however, was that 
between GMP1  and ubiquitin (Fig. 6 B). The homology 
with ubiquitin began  after the divergent amino-terminal 
domain found in GMP1 (which is absent from ubiquitin) 
and extended over the entire length of the second domain. 
Furthermore, a  signature feature of ubiquitin,  an invari- 
able double glycine at the carboxyl terminus, is conserved 
in GMP1 and in all of the GMPl-related proteins (Fig. 6 B). 
This double glycine is essential for the proteolytic process- 
ing of ubiquitin precursors and for the recycling of post- 
translationally  synthesized  polyubiquitin  (Hershko  and 
Ciechanover, 1992; Wilkinson, 1995). Similar to ubiquitin 
The Journal of Cell Biology, Volume 135,  1996  1462 Figure 5.  The 90-kD form of RanGAP1 localizes to the cytoplasmic fibers of the NPC. Isolated nuclear envelopes were fixed and incu- 
bated with a combination of three RanGAPl-specific mAbs (19C7, 2F1, and 19G12) followed by incubation with goat anti-mouse IgG 
conjugated to 10-nm gold. Samples were processed for thin sectioning and observed by EM. (A) A section of nuclear envelope demon- 
strating the typical labeling pattern observed. The cytoplasmic side of the nuclear envelope (evidenced by occasional blebs in the mem- 
brane) is oriented towards the outside. (B) A high magnification view along a single length of envelope. The cytoplasmic side of the en- 
velope is oriented towards the  top.  (C)  A  high magnification view of a  single NPC,  demonstrating localization to the tips of the 
cytoplasmic fibers. Bars: (A) 1 ~m; (B and C) 0.1 ~m. 
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GGGAAGGGAGAAGGATTCGTAAACCCCGGAGCGAGGTTCTGCTTACCCGAGGCCGCTGCT 
GTGCGGAGACCCCCGGGTGAAGCCACCGTCATCATGTCTGACCAGGAGGCAAAACCTTCA  120 
MSOOEAKPS 
ACTGAGGACTTGGGGGATAAGAAGGAAGGTGAATATATTAAACICAAAGTCATTGGACAG  180 
T  E  O  L  O  D  K  K  E  O  E  Y  I  K  L  K  V  I  G  O 
GATAGCAGTGAGATTCACTTCAAAGTGAAAATGACAACACATCTCAAGAAACTCAAAGAA  240 
O  S  S  E  I  H  F  K  V  K  M  T  T  H  L  K  K  L  K  E 
TCATACTGTCAAAGACAGGGTGTTCCAATGAATTCACTCAGGTITCTCTTTGAGGGTCAG  300 
S  Y  C  Q  R  Q  G  V  P  M  N  S  L  R  F  L  F  E  G  Q 
AGAATTGCTGATAATCATACTCCAAAAGAACTGGGAATGGAGGAAGAAGATGTGATTGAA  360 
RIADNHTPKELGMEEEDVIE 
GTTTATCAGGAACAAACGGGGGGTCATTCAACAGTTTAGATATTCTTTTTATTTTTTTTT 420 
V  Y  O  E  Q  T  G  G  H  S  T  V  • 
TTTTCCCTCAATCCTTTTTTATTTTTAAAAATAGTTCTTTTGTAATGTGGTGTTCAAAAC  480 
GGAATTGAAAACTGGCACCCCATCTCTTTGAAACATCTGGTAATTTGAATTCTAGTGCTC  540 
ATTATTCATTATTGTTTGTTTTCATT~TGCTGATTTTTGGTGATCAAGCCTCAGTCCC..  598 
Figure 6.  GMP1 is homologous to ubiquitin,  and 
it is highly conserved from human to yeast. (A) 
Partial DNA sequence of EST eDNA clone 32220 
and the predicted amino acid sequence  of GMP1. 
The  underlined  amino  acids  were  also  derived 
from peptide sequence analysis (see Fig. 2 B). (B) 
Amino acid sequence alignments between human 
ubiquitin,  GMP1,  and  GMPl-related  proteins. 
Residues identical in three or more of the aligned 
proteins are shaded.  Asterisks  indicate  identical 
residues  in GMP1 and ubiquitin. The primary se- 
quence of human ubiquitin is as first described by 
Schlesinger  et  al.  (1975). The  remaining  se- 
quences,  with the exception of 1t. sapiens H and 
the yeast homologue, were identified  as predicted 
translations  of EST clones.  The human GMP1- 
related protein (H. sapiens 11) was derived from 
the HSMT3 cDNA (Mannen et al., 1996). The C. 
elegans homologue  was  compiled  from  clones 
with  GenBank accession  Nos.  D76147, D73158, 
and T02042, and the rice homologue (O. sativa) 
was  derived  from clones  D15376 and  D22620. 
The yeast sequence (S. cerevisiae)  is derived from 
a cDNA clone  coding Smt3p  (Meluh  and Kosh- 
land, 1995). 
precursors  (all known  ubiquitins  are  synthesized  as pre- 
cursors with carboxyl-terminal extensions, or as polyubiq- 
uitin),  the  double  glycines present  in  GMP1  and  in  the 
GMPl-related  proteins  are  not  at  the  extreme carboxyl 
terminus. The presence of this double glycine in the car- 
boxyl-terminal domain of GMP1, followed by a short vari- 
able domain, suggests that GMP1  and ubiquitin  may un- 
dergo  similar  enzymatic  transformations.  At  the  same 
time, the overall identity with ubiquitin is only 18%, iden- 
tifying GMP1 as a novel ubiquitin-like protein. 
To further characterize GMP1, recombinant protein was 
produced in bacteria and used to generate mAbs. GMP1- 
specific antibodies were identified by immunofluorescence 
and immunoblot analysis. The antibodies were first used 
to demonstrate that GMP1 and the 90-kD form of RanGAP1 
are  covalently  associated.  Nuclear  envelope-associated 
RanGAP1 was immunopurified after denaturation in SDS 
with  a  RanGAPl-specific mAb. Immunoblot analysis of 
the immunopurified protein was then performed using an 
mAb against GMP1  (the specificity of these antibodies is 
demonstrated in Fig. 10). Antibodies against GMP1 recog- 
nized a 90-kD protein among total nuclear envelope pro- 
teins (Fig. 7, lane 1) and a 90-kD polypeptide immunopu- 
rifled with the anti-RanGAP1 antibody (Fig. 7, lane 2). No 
signal was detected among proteins immunopurified with 
the control antibody SP2/0  (Fig. 7, lane 3). These results 
indicate  that  RanGAP1-  and  GMPl-specific  antibodies 
recognize  the  same protein  or two covalently associated 
proteins. The homology between GMP1  and ubiquitin  is 
suggestive of the latter possibility. Furthermore, Northern 
blot analysis with probes specific for GMP1 and RanGAP1 
revealed distinct mRNA transcripts of 1.4 and 3.0 kb, re- 
spectively. No  indication  of a  single,  common transcript 
encoding both proteins was detected by Northern blot or 
reverse-transcription PCR (data not shown). 
GMPI Colocalizes to the NPC with RanGAP1 and It Is 
Also Present in the Nucleus 
Immunofluorescence  microscopy on  formaldehyde-fixed 
and acetone-permeabilized BRL cells detected  GMP1 in 
the nucleus and associated with the nuclear envelope (Fig. 
8  a).  The  intranuclear  signal  was  largely homogeneous; 
however,  the  antigen  was  also  concentrated  in  foci that 
varied widely in number and in intensity from cell to cell. 
The signal associated with the nuclear envelope was most 
apparent when the cells were permeabilized with digitonin 
before fixation and labeling, and it was very similar to the 
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GMP1 are covalently associ- 
ated.  Isolated  nuclear  enve- 
lopes  were  solubilized  with 
SDS (lane 1), and the 90-kD 
form of RanGAP1 was immu- 
nopurified with the RanGAP1- 
specific mAb 19C7 (lane 2). 
A  control  immunopurifica- 
tion was performed with an- 
tibody derived from the my- 
eloma cell line SP2/0 (lane 3). 
Proteins  were  separated  by 
SDS-PAGE  (12.5%  acryl- 
amide), transferred to nitrocel- 
lulose membrane, and probed 
with the GMPl-specific mAb 
21C7. Antibody heavy chains 
(h.c.) and  light  chains  (l.c.) 
are indicated on the right. 
signal  observed with antibodies  to RanGAP1  (Figs.  3  b 
and 8 b). Also, during mitosis, the localization of GMP1 
appeared very similar to that of RanGAP1. Signal was de- 
tected throughout the cells concomitant with the break- 
down of the nuclear envelope at prophase (Fig. 8 c), but 
also associated with the mitotic spindles during metaphase 
and anaphase (Fig. 8, d and e). By early telophase, GMP1 
could be seen concentrated around the newly condensed 
chromatin (Fig. 8 J0. Like the 90-kD form of RanGAP1, 
GMP1 was also sublocalized to the NPC by immunogold 
EM (data not shown). 
Immunoblots of total BRL cell lysate probed with anti- 
bodies against  GMP1  revealed a  major signal  at 90 kD, 
identifying the 90-kD form of RanGAP1  as the primary 
cellular protein associated with GMP1 (Fig. 9, lane 1). Sig- 
nificantly less prominent proteins were also detected, how- 
ever, including a polypeptide with an apparent molecular 
mass of 50 kD, and a large number of proteins migrating 
above 116 kD. All of these proteins are presumably cova- 
lent conjugates formed between GMP1 and other cellular 
proteins. To determine the subcellular localization of these 
proteins, digitonin-soluble and -insoluble fractions (similar 
to those in Fig. 4) were also probed. As expected for the 
90-kD form of RanGAP1, the 90-kD protein recognized 
by  GMPl-specific  antibodies  was  also  found  predomi- 
nantly in the digitonin-insoluble fraction (Fig. 9, lane 2). 
The high molecular mass proteins fractionated exclusively 
with the digitonin-insoluble fraction (Fig. 9, lane 2), and 
these  antigens  likely account for the  intranuclear signal 
observed by immunofluorescence microscopy. The protein 
migrating at 50 kD, on the other hand, fractionated exclu- 
sively with the digitonin-soluble fraction (Fig.  8,  lane 3) 
and is likely to be a cytoplasmic protein. Only a very weak 
signal  was  detected  at  17  kD,  presumably representing 
free GMP1. The levels of free GMP1 may be underrepre- 
sented,  since  it  is  possible  that  the  antibody recognizes 
conjugated GMP1 better than it does free GMP1 (see Fig. 
10). These data further support the association of GMP1 
with RanGAP1, and they demonstrate the association of 
GMP1 with additional cellular proteins, predominantly in 
the nucleus. 
The Association between RanGAP1 and GMP1 Can Be 
EnzymaticaUy Reversed by an Activity that Fractionates 
with NPCs 
During  the  course of fractionating nuclear envelopes, it 
was observed that  the 90-kD form of RanGAP1  consis- 
tently disappeared upon extraction of the PCLF (an insol- 
uble fraction derived from extraction of isolated nuclear 
envelopes with Triton X-100) with the ionic detergent Em- 
pigen BB. Whereas the majority of nucleoporins present 
in the PCLF were quantitatively solubilized with Empigen 
BB, the 90-kD form of RanGAP1 was not detected in ei- 
ther the supematant or the pellet fractions (Fig. 10, lanes 1 
and 2; pellet fraction not shown).  Concomitant with the 
disappearance of the 90-kD form of RanGAP1, however, 
a  70-kD  protein not  observed in  previous fractions ap- 
peared in the Empigen supernatant (Fig. 10, lanes 1 and 
2). Immunoblot analysis of the PCLF and the Empigen su- 
pernatant  fractions with  an  antibody against  RanGAP1 
demonstrated that the 90-kD form of RanGAP1 had been 
precisely converted to a protein that comigrates with the 
70-kD form (Fig. 10, lanes 3 and 4). At the same time, the 
antigen recognized by GMPl-specific antibodies was con- 
verted to a protein with an apparent mass of 17 kD (Fig. 
10, lanes 6 and 7). Given the homologies between GMP1 
and ubiquitin, this result can be interpreted as a "deubiq- 
uitination" of RanGAP1 by a specific protease that copu- 
rifles with the PCLF. To support this interpretation, the 
PCLF  was  preincubated  with  the  sulfhydryl  alkylating 
agent NEM before extraction with Empigen BB. NEM is a 
potent inhibitor of the peptidases responsible for cleaving 
ubiquitin/substrate  isopeptide  bonds  (Johnson,  E.,  per- 
sonal communication). Consistent with the involvement of 
a specific peptidase in the release of GMP1 from RanGAP1, 
NEM greatly inhibited the conversions detected in mock- 
treated fractions (Fig.  10, lanes 5  and 8). These data are 
consistent with the interpretation that the 90-kD form of 
RanGAP1  originates  through  a  covalent and  reversible 
linkage to GMP1 by a pathway that is analogous to ubiq- 
uitination. 
Discussion 
We  have  identified  a  novel  ubiquitin-like  modification 
that correlates with the partitioning of the Ran GTPase- 
activating protein RanGAP1 from the cytosol to the NPC. 
These findings have specific implications for the function 
Matunis et al. A Novel Ubiquitin-like  Modification  of  RanGAP1  1465 Figure 8.  GMP1 localizes to the nucleus and the nuclear envelope during interphase,  and to the mitotic spindle during mitosis. BRL 
cells were grown on coverslips, fixed, and permeabilized  as indicated before incubation with mAb 21C7. (a) Immunofluorescence  on 
cells fixed and permeabilized with acetone. (b) Localization of GMP1 in cells permeabilized with digitonin before fixation. (c) Localiza- 
tion in cells at prophase. Cells were first fixed and then permeabilized with acetone. (d) Localization in cells at metaphase. Cells were 
permeabilized with digitonin before fixation. (e) Localization at anaphase in cells permeabilized with digitonin before fixation. (10 Lo- 
calization at telophase in cells permeabilized with digitonin before fixation. Bars: (a and b) 10 i~m; (c-f) 8 ~m. 
of Ran in mediating nuclear import, and more general im- 
plications for the diversity of ubiquitin modifications and 
their functions. Ubiquitin is a 76-amino acid, highly con- 
served  protein  that  is  universally present  in  eukaryotic 
cells. Its covalent attachment to a variety of cellular proteins 
is catalyzed by a family of ubiquitin-conjugating (E2) en- 
zymes that mediate the formation of an isopeptide bond 
between the carboxyl-terminal glycine of ubiquitin and 
the •  amino group of a lysine residue in an acceptor pro- 
tein (Hershko and  Ciechanover, 1992;  Wilkinson,  1995). 
Equally important to their conjugation, ubiquitin subunits 
are  also  removed by ubiquitin  carboxyl-terminal hydro- 
lases  (isopeptidases),  making  ubiquitination  a  reversible 
and  regulatable  posttranslational  modification (Hershko 
and Ciechanover, 1992; Wilkinson, 1995). While ubiquitin- 
mediated proteolysis is the best-studied function of ubiq- 
uitin conjugation, it has also been implicated in regulating 
a  host of other cellular processes, including endocytosis 
and vacuolar targeting, protein kinase activation, protein 
import  into  mitochondria,  and  peroxisome  biogenesis 
(Ciechanover,  1994;  Wilkinson,  1995;  Chen  et  al.,  1996; 
Egner and Kuchler, 1996;  Galan et al.,  1996;  Hicke and 
Riezman, 1996; Roth and Davis, 1996; Strous et al.,  1996). 
The utility of the ubiquitin system raises the question of 
whether parallel pathways exist, using novel ubiquitin-like 
proteins. At the present time, only several examples exist, 
including an IFN-inducible ubiquitin homologue that con- 
jugates to a large number of intracellular proteins (Loeb 
and Haas, 1992), as well as a viral-encoded ubiquitin-like 
protein (Haas et al.,  1996). Whereas the function of the 
IFN-inducible  protein  is  currently  uncertain,  the  viral- 
encoded ubiquitin-like protein may function to block deg- 
radation of short-lived proteins by the host. 
Here, we report the existence of a new family of ubiq- 
uitin-like proteins that likely serve novel functions through 
their conjugation to specific protein substrates. We identi- 
fied the first member of this family as a covalent modifica- 
tion of the 70-kD Ran GTPase-activating protein RanGAP1, 
and we have named it GMP1  (for GAP modifying pro- 
tein 1). Evidence for a covalent and reversible association 
between RanGAP1 and GMP1 included (a) derivation of 
peptide sequences for both RanGAP1 and GMP1 from a 
single protein migrating at 90 kD; (b) coimmunopurifica- 
tion  of  RanGAP1  and  GMP1  antigens  under  protein- 
denaturing conditions; and (c) specific enzymatic conver- 
sion of the 90-kD form of RanGAP1  to the free 70-kD 
form of RanGAP1  and  free  GMP1.  Evidence  that  the 
modification occurs posttranslationally included (a) detec- 
tion of unique, nonoverlapping mRNAs coding for RanGAP1 
and  GMP1  by Northern blot analysis and  RT-PCR;  (b) 
overlapping but unique subcellular distributions of RanGAP1 
and GMP1  in cultured cells; and (c) rapid, phosphoryla- 
tion-dependent conversion of the 70-kD form of RanGAP1 
to the 90-kD form in vivo (Matunis, M.J., and G. Blobel, 
unpublished results). 
While the exact function of the ligation between RanGAP1 
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predominantly with RanGAP1, 
but also with additional sub- 
strates  in the nucleus and in 
the  cytoplasm.  BRL  cells 
were either lysed directly in 
SDS-PAGE  sample  buffer 
(lane 1), or were fractionated 
into  a  digitonin  insoluble 
fraction (lane 2),  and a digi- 
tonin  soluble  fraction  (lane 
3).  Proteins  were  separated 
by  SDS-PAGE  (15%  poly- 
acrylamide),  transferred  to 
nitrocellulose  membrane, and 
probed with mAb 21C7. 
and  GMP1  remains  to  be  determined,  the  modification 
correlated with localization of RanGAP1 to the NPC. Im- 
munofluorescence and immunoblot  analysis of digitonin- 
extracted  cells  revealed  that  while  the  modified  form of 
RanGAP1  is  predominantly  associated  with  the  nuclear 
envelope, the 70-kD unmodified form is strictly cytoplas- 
mic. Approximately 15% of the 90-kD form of RanGAP1 
was detected in the digitonin-extracted fraction; however, 
it remains to be determined whether this represents a true 
cytoplasmic pool, or more simply,  protein  released  from 
the nuclear envelope during the fractionation procedure. 
Equivalent  amounts  of  the  70-kD  unmodified  form  of 
RanGAP1  and  the  90-kD  modified  form  of  RanGAP1 
were  detected  in  whole  lysates.  Based  on the  apparent 
size of free recombinant GMP1  on SDS gels (17 kD), we 
estimate  that  a  single  copy  of  GMP1  is  attached  to 
RanGAP1.  Unlike  the  majority  of ubiquitin  conjugates, 
no  evidence  for ligation  of multiple  copies  of GMP1  to 
RanGAP1  was detected,  and we have  no evidence for a 
role  in  protein  degradation.  GMP1  may not  form ubiq- 
uitin-like polymers because the lysine residues of ubiquitin 
that have been reported  to form such chains  (most com- 
monly lysine 48) are not conserved in GMP1. 
RanGAP1 has previously been purified from HeLa cells 
using a  biochemical assay for RanGAP activity (Bischoff 
et al.,  1994).  Approximately equal levels of RanGAP ac- 
tivity were  detected  in nuclear  and cytoplasmic fractions 
derived  from interphase  HeLa  cells,  and  both  activities 
were ultimately attributed  to the 70-kD unmodified form 
Figure 10.  The 90-kD form of RanGAP1 is enzymatically pro- 
cessed into the 70-kD form of RanGAP1 and free GMP1. The 
pore complex lamina fraction (PCLF) was extracted with the ionic 
detergent Empigen BB after treatment with DTF and NEM, or 
after treatment with NEM alone. The PCLF and proteins solubi- 
lized by Empigen were separated by SDS-PAGE (10 or 12.5% 
acrylamide) and visualized  by silver stain (lanes I  and 2), or they 
were transferred to nitrocellulose membrane and probed with the 
RanGAPl-specific mAb 19C7 (lanes 3-5) or with the GMPl-spe- 
cific mAb 21C7 (lanes 6--8). Extraction with Empigen after mock 
treatment with NEM resulted in conversion of the 90-kD form of 
RanGAPI to the 70-kD form (lanes 3 and 4), with a concurrent 
shift in GMPl-reactive proteins from 90 to 17 kD (lanes 6 and 7). 
Conversions were inhibited by preincubation of the PCLF with 
the  alkylating agent NEM before Empigen extraction  (lanes 5 
and 8). The lower portion of the immunoblots were overexposed, 
since the level of free GMP1 that was detected was not equiva- 
lent to the level of the 90-kD RanGAP1 (either resulting from a 
lower reactivity of the antibody for free GMP1 or from less free 
GMP1 being present on the blot). 
of RanGAP1. Because  our findings demonstrate  that the 
unmodified  form  of RanGAP1  is  strictly  cytosolic, it  is 
likely that the nuclear RanGAP1 purified in this study was 
converted from the GMPl-modified form to the unmodified 
form during the course of its purification (possibly during 
the 400 mM NaC1 extraction of the nuclear pellet). Prece- 
dence for demodification of nuclear-associated RanGAP1 
is provided by the specific release of GMP1 from RanGAP1 
after detergent extraction  of the isolated PCLF (Fig.  10). 
With this consideration,  RanGAP activity detected in as- 
sociation  with  the  nuclear  pellet  would  indicate  that  the 
modified form of RanGAP1 is an active GAP. Because anti- 
bodies specific for mammalian  RanGAP1 were not previ- 
ously available, the 90-kD form of RanGAP1 was not de- 
tected by immunoblot analysis. 
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localized to the cytoplasmic fibers of the NPC. Approxi- 
mately 5 % of the signal detected on isolated nuclear enve- 
lopes was also localized to the nucleoplasmic side of the 
NPC. This relative distribution is consistent with results 
obtained by immunofluorescence microscopy, where the 
majority of the signal was detectable from the cytoplasmic 
side  of the  nuclear  envelope.  RanGAP1  has  previously 
been considered a cytosolic factor, and models concerning 
how Ran functions to mediate nuclear import have taken 
this into account by postulating the existence of additional 
RanGAPs, or a  requirement for Ran to shuttle between 
the nucleus and cytoplasm (Rush et al., 1996; Sazer, 1996). 
Localization of RanGAP1 to the cytoplasmic fibers of the 
NPC obviates the need for Ran to enter the cytoplasm to 
complete its GTP/GDP cycle, and strongly implicates the 
fibers as one of the major sites of RanGTPase activity and 
a critical regulatory point in protein import. We envision 
two  models for Ran-mediated  nuclear  import based  on 
Ran-GTP hydrolysis at this site. First, Ran-GTP hydroly- 
sis at the cytoplasmic fibers of the NPC could be directly 
linked  to release  of docked  karyopherin/substrate  com- 
plexes and the commitment of these complexes to subse- 
quent phases of translocation, as proposed recently (Mel- 
chior et al., 1995). Nup358, which is one component of the 
cytoplasmic fibers, potentially binds Ran-GTP and karyo- 
pherin/substrate  complexes, and it would therefore be a 
likely site for this initial event.  Subsequent  steps  in the 
translocation  process  would  not  require  Ran,  although 
Ran-GTP would have to be regenerated, presumably after 
translocation of Ran-GDP into the nucleus and interac- 
tion with RCC1.  As  an alternative model (although not 
necessarily exclusive), Ran-GTP hydrolysis could mediate 
the  release  and  import  of  karyopherin/substrate  com- 
plexes indirectly by simply serving to generate Ran-GDP. 
As recently demonstrated, the Ran-interactive protein pl0 
can function to coordinate dissociation of docked karyo- 
pherin receptor complexes by mediating the formation of 
a  pentameric complex of Ran-GDP, pl0,  karyopherin-tx 
and  -[3, and  nucleoporin.  Dissociation  of docked  com- 
plexes is proposed to be mediated by the association of in 
situ-generated Ran-GTP with karyopherin-[3. According 
to this model, Ran would function at multiple steps in the 
translocation  process,  mediating  dissociation  of docked 
complexes along the length of the  NPC.  Karyopherin-[3 
would have to be regenerated either by GTP hydrolysis 
(presumably at the cytoplasmic fibers of the NPC) or by 
exchange of GTP for GDP in the nucleus, mediated by 
RCC1. 
Rates of nuclear import vary depending on physiologi- 
cal conditions (Feldherr and Akin, 1994). According to ei- 
ther model presented above, the relative rates of nuclear 
import could be limited directly by the concentration of 
RanGAP1  at the NPC.  In addition, the  NPC-associated 
RanGAP1 could also be positioned to control rates of nu- 
clear import indirectly by regulating the concentration of 
Ran-GTP in the cytosol. Considering the nucleus to be the 
primary  source  of Ran-GTP,  both  the  modified  90-kD 
form of RanGAP1  and Nup358  could be positioned to 
capture  and  hydrolyze Ran-GTP  diffusing  through  the 
NPC. Levels of Ran-GTP in the cytosol are potentially sig- 
nificant,  since  complexes  formed  with  karyopherin-[3 
could inhibit nuclear import by preventing karyopherin- 
ct/13 heterodimers from forming (Rexach and Blobel, 1995). 
The relative concentrations of RanGAP1 at the NPC could, 
therefore, be used to regulate the overall rates of nuclear 
import both directly and indirectly. Conjugation of GMP1 
to RanGAP1 correlates with its association with the NPC, 
and it could in turn serve to regulate the relative concen- 
tration of RanGAP1 associated with the NPC. 
At least three possible scenarios can be envisioned for 
how GMP1  may mediate association of RanGAP1  with 
the NPC. First, GMP1 itself may bind directly to a compo- 
nent of the fibers, thereby tethering RanGAP1 to the NPC. 
This scenario is not immediately favored, given the detec- 
tion of GMP1 both in the cytoplasm and in the nucleus, 
possibly ligated to additional protein substrates. Alterna- 
tively, ligation of GMP1 may function to expose a bind- 
ing site on RanGAP1 that would be masked in the unmod- 
ified protein. The 70-kD unmodified form of RanGAP1 
forms a homodimer (Bischoff et al., 1994), and GMP1 liga- 
tion could potentially disrupt  dimer formation, allowing 
RanGAP1 to interact with a protein at the NPC. It is inter- 
esting to note that both RanGAP1 and Nup358 have leu- 
cine-rich motifs, which are potential protein-protein inter- 
action domains. Finally, a combination of these two scenarios 
may occur, whereby ligation of GMP1 creates a  binding 
site with residues from RanGAP1 and GMP1 contributing 
to association with the NPC. We are currently investigat- 
ing the details of how modifications of RanGAP1, includ- 
ing phosphorylation and ligation of GMP1, affect the sub- 
cellular localization of RanGAP1. In addition to affecting 
its localization, it is also possible that ligation of GMP1 to 
RanGAP1 alters its enzymatic activity as a Ran-GTPase- 
activating protein. Biochemical analysis of the 70-kD un- 
modified form of RanGAP1  demonstrated it to be a po- 
tent RanGTPase activator (Bischoff et al., 1994).  At the 
present time, we have detected significant RanGAP activ- 
ity associated with isolated nuclear envelopes (Coutavas, 
E., and G. Blobel, unpublished data), suggesting that the 
90-kD modified form of RanGAP1 is also active. 
In addition to localization at the NPC, it was also ob- 
served that antibodies specific for both RanGAP1 and for 
GMP1 recognized the mitotic spindle apparatus in divid- 
ing cells, suggesting that the 90-kD form of RanGAP1 re- 
localizes from the NPC to the spindles during mitosis. This 
finding is particularly interesting in light of the observa- 
tions that implicate Ran as a regulator of nuclear structure 
and entry into mitosis (Kornbluth et al., 1994; Clarke et al., 
1995). Localization of RanGAP1 at the spindle implicates 
this structure as a point for the release of Ran-GTP from a 
mitotic effector molecule. Microtubules may be one such 
effector of the Ran pathway during mitosis, since overex- 
pression of RCC1 in yeast suppresses mutations of et-tubu- 
lin that arrest with excess microtubules (Kirkpatrick and 
Solomon, 1994).  Regulatory interactions (direct or indi- 
rect) between Ran and microtubules could, therefore, act 
as one signal for cell cycle progression. A second potential 
target of the Ran pathway at the mitotic spindles is NuMA, 
a  236-kD  intranuclear  protein  that  associates  with  the 
pericentrosomal domain of the spindle apparatus  during 
mitosis. Ectopic expression of NuMA lacking its globular 
head domain results in cells with a phenotype morphologi- 
cally identical to that of temperature-sensitive mutants of 
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tially  suppress  the  phenotype  of  temperature-sensitive 
mutant RCC1 cells (Compton and Cleveland, 1993). It re- 
mains to be determined whether these properties  result 
strictly from a failure to reimport NuMA into the nucleus 
after  mitosis.  Finally,  the  yeast  homologue  of  GMP1, 
Smt3p, was originally identified as a suppressor of the MIF2 
gene, whose protein product is a centromere protein re- 
quired for mitotic spindle integrity (Meluh and Koshland, 
1995). It is presently unkown whether Smt3p also localizes 
to the spindle in yeast and whether it is conjugated to the 
RanGAP1 homologue. At the present time, immunoblot 
analysis has revealed only one  (apparently unmodified) 
form of RanGAP1  in S.  cerevisiae (Hopper et al., 1990; 
Koepp  et  al.,  1996).  If  the  90-kD  modified  form  of 
RanGAP1 proves specifically to localize to the spindles, 
conjugation with  GMP1  may be  an  important determi- 
nant. It is interesting to note that a second yeast ubiquitin- 
like protein, Dsk2p, has also been identified as a factor in- 
volved in mitotic spindle formation (Biggins et al., 1996). 
In conclusion, our findings have specific implications for 
the function of Ran in mediating nuclear import, and for 
the use of ubiquitin-like modifications to regulate cell pro- 
cesses. We have characterized just one of a new family of 
ubiquitin-like proteins and found it to be conjugated with 
relative specificity to RanGAP1. In addition to GMP1, we 
identified mammalian cDNAs that encode two additional 
GMPl-related proteins. Given the indications that GMP1 
ligation has specific function(s) distinct from the signaling 
protein degradation of RanGAP1, characterization of these 
homologues and their substrates will be of interest. At the 
present time, the enzymology  of GMP1 ligation to RanGAP1 
is not known, although we have identified an activity that 
appears to reverse the modification. Surprisingly, this ac- 
tivity was detected in a highly enriched pore complex lam- 
ina fraction, indicating that the activity may be associated 
with the NPC. Because Empigen extraction leads to the 
solubilization of the majority of proteins associated with 
the PCLF (with the exception of the lamins and several 
lamin-associated proteins),  it  is  likely that  the  putative 
peptidase is solubilized along with RanGAP1. Solubiliza- 
tion of both substrate and enzyme could allow their inter- 
action and may explain the observed peptidase  "activa- 
tion." While the significance of this peptidase activity is 
presently unknown, it may potentially control regulated 
release  of RanGAP1  from  the  NPC.  This  activity and 
other regulators of this novel RanGAP1 modification are 
being investigated. 
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Note added in proof.  While this manuscript was being reviewed, another 
group has published the finding that GMP1 interacts with the PML com- 
ponent of a multiprotein complex that is disrupted in acute promyelocytic 
leukemia (Boddy, M.N., K. Howe, L.D. Etkin, E.Solomon, and P.S. Free- 
mont. 1996. Oncongene.  13:971-982).  Consistent with our immunodetec- 
tion of GMP1 in brightly stained spots in the nucleus, Boddy et al. demon- 
strated that GMP1 localizes  to distinct  structures in the nucleus known as 
PML  nuclear  bodies.  At  the  present  time,  there  is  no  evidence  that 
RanGAP1 also localizes to these structures. 
References 
Adam, EJ., and S.A. Adam. 1994. Identification  of cytosolic factors required 
for nuclear location sequence-mediated  binding to the nuclear envelope. Z 
Cell Biol. 125:547-555. 
Adam, S.A., R.S. Mart, and L. Gerace. 1990. Nuclear protein import in perme- 
abilized mammalian cells requires  soluble cytoplasmic factors. J.  Cell Biol. 
111:807-816. 
Beddow, A.L., S.A. Richards, N.R. Orem, and I.G. Macara. 1995. The Ran/TC4 
GTPase-binding domain: identification by expression cloning and character- 
ization of a conserved sequence motif. Proc. Natl. Acad. Sc£ USA. 92:3328-- 
3332. 
Biggins, S., 1. Ivanovska, and M.D. Rose. 1996. Yeast ubiquitin-like genes are 
involved in duplication  of the  microtubule  organizing center. J.  Cell Biol. 
133:1331-1346. 
Bisehoff, F.R., C.  Klebe, J.  Kretschmer,  A. Wittinghofer,  and  H. Ponstingl. 
1994. RanGAP1  induces GTPase activity of nuclear Ras-related  Ran. Proc. 
Natl. Acad. Sci. USA. 91:2587-2591. 
Bischoff, F.R., H. Krebber, T. Kempf, I. Hermes, and H. Ponstingl. 1995a. Hu- 
man RanGTPase-aetivating  protein  RanGAP1  is  a  homologue  of yeast 
Rnalp involved in mRNA processing and transport.  Proc. Natl. Acad. Sci. 
USA. 92:1749-1753. 
Bisehoff, F.R., H. Krebber,  E. Smirnova, W. Dong, and H. Ponstingl. 1995b. 
Co-activation  of RanGTPase  and  inhibition  of GTP dissociation by Ran- 
GTP binding protein RanBP1. EMBO (Fur. Mol. Biol. Organ.) Z  14:705-715. 
Bischoff, F.R., G. Maier, G. Tilz, and H. Ponstingl. 1990. A 47-kDa human nu- 
clear protein recognized by antikinetochore  autoimmune sera is homologous 
with the protein  encoded by RCC1, a gene implicated in onset of chromo- 
some condensation. Proc. Natl. Acad. Sci.  USA. 87:8617-8621. 
Bischoff, F.R.,  and  H.  Ponstingl.  1991. Catalysis  of guanine  nucleotide  ex- 
change on Ran by the mitotic regulator RCC1. Nature (LontL). 354:80--82. 
Blobel, G., and V.R. Potter.  1966. Nuclei from rat liver: isolation method that 
combines purity with high yield. Science (Wash. DC). 154:1662-1665. 
Bourne, H.R., D.A. Sanders, and F. McCormick. 1991. The GTPase superfam- 
ily: conserved  structure and molecular  mechanism.  Nature (Loud.).  349: 
117-127. 
Chen, Z.J., L  Parent,  and T. Maniatis. 1996. Site-specific phosphorylation  of 
IKBa by a novel ubiquitination-dependent  protein  kinase activity. Cell. 84: 
853-862. 
Chi, N.C., E. Adam, and S.A. Adam.  1995. Sequence and characterization  of 
cytoplasmic nuclear protein import factor p97. J. Cell Biol. 130:265-274. 
Choi, Y.D., and G. Dreyfuss. 1984. Monoclonal  antibody  characterization  of 
the C proteins  of heterogeneous  nuclear  ribonueleoprotein  complexes in 
vertebrate  cells. J. Cell Biol. 99:1997-2004. 
Ciechanover, A. 1994. The ubiquitin-proteasome  proteolytic pathway. Cell. 79: 
13-21. 
Clarke, P.R., C. Ktebe, A. Wittinghofer,  and E. Karsenti.  1995. Regulation of 
Cdc2tcyclin B activation  by Ran, a  Ras-related  GTPase.  J.  Cell Sci.  108: 
1217-1225. 
Compton, D.A., and D.W. Cleveland. 1993. NuMA is required  for the proper 
completion of mitosis. J. Cell Biol. 120:947-957. 
Coutavas, E., M. Ren, J.D. Oppenheim, P. D'Eustachio,  and M.G. Rush. 1993. 
Characterization  of proteins that interact with the cell-cycle regulatory pro- 
tein Ran/TC4. Nature (Lond.). 366:585-587. 
Dasso, M. 1993. RCC1 in the cell cycle: the regulator  of chromatin condensa- 
tion takes on new roles. Trends. Biochem. ScL 18:96-101. 
Davis, L., and G. Blobel. 1986. Identification and characterization  of a nuclear 
pore complex protein. Cell. 45:699-709. 
DeGregori,  J., A. Russ, H. you Melchner,  H. Rayburn,  P. Priyaranjan,  N.A. 
Jenkins, N.G. Copeland,  and H.E.  Ruley. 1994. A murine  homolog of the 
yeast RNA1 gene is required for postimplantation development. Genes Dev. 
8:265-276. 
Dreyfuss, G., S.A. Adam, and Y.D. Choi. 1984. Physical change in cytoplasmic 
messenger ribonucleoproteins  in cells treated with inhibitors of mRNA tran- 
scription. Mol. Cell. Biol. 4:415-423. 
Dwyer, N., and G. Blobel. 1976. A modified procedure  for the isolation of a 
pore complex-lamina fraction from rat liver nuclei. J. Cell Biol. 70:581-591. 
Egner, R., and K. Kuchler. 1996. The yeast multidrug transporter Pdr5 of the 
plasma membrane is ubiquitinated  prior to endocytosis and degradation  in 
the vacuole. FEBS Lett. 378:177-181. 
Enenkel,  C., G. Blobel, and M. Rexach. 1995. Identification  of a yeast karyo- 
pherin heterodimer  that targets import substrate to mammalian nuclear pore 
complexes. Z Biol. Chem. 270:16499-16502. 
Feldherr, C.M., and D. Akin. 1994. Role of nuclear trafficking in regulating cel- 
lular activity. Int. Rev. Cytol. 151:183-228. 
Fernandez,  J., M. DeMott, D. Atherton,  and S. Mische. 1992. Internal  protein 
Matunis et al. A Novel Ubiquitin-like Modification of RanGAPl  1469 sequence analysis: enzymatic digestion for tess than 10 micrograms of pro- 
tein bound to polyvinylidine difluoride or nitrocellulose membranes. AnaL 
Biochem. 201:255-264. 
Galan, J.M., V. Moreau,  B. Andre,  C. Volland,  and T.R. Haguenauer.  1996. 
Ubiqultination  mediated  by the Npilp/Rsp5p ubiquitin-protein  ligase is re- 
quired  for endocytosis of the yeast  uracil  permease.  J.  Biol.  Chem.  271: 
10946-10952. 
G6rlich, D., S. Kostka, R. Kraft, C. Dingwall, R.A. Laskcy, E. Hartmann,  and 
S. Prehn.  1995. Two different subunits of importin cooperate  to recognize 
nuclear localization signals and  bind them to the  nuclear  envelope.  Curt. 
Biol. 5:383-392. 
G6rlich, D., S. Prehn, R.A. Laskey, and E. Hartmann.  1994. Isolation of a pro- 
tein that is essential  for the first step of nuclear  protein import.  Cell.  79: 
767-778. 
Haas, A.L., D.J. Katzung, P.M. Reback,  and L.A. Guarino.  1996. Functional 
characterization  of the  ubiquitin  variant  encoded  by the baculovirus Au- 
tographa californica. Biochemistry. 35:5385-5394. 
HartweU, L. 1967. Macromolecular synthesis in temperature-sensitive  mutants 
of yeast. J. Bacteriol. 93:1662-1670. 
Hershko, A., and A. Ciechanover. 1992. The ubiquitin system for protein deg- 
radation. Annu. Rev. Biochem. 61:761-807. 
Hicke, L., and H. Riezman. 1996. Ubiqultination  of a yeast plasma membrane 
receptor signals its ligand-stimulated endocytosis. CelL 84:277-287. 
Hopper, A.K., H.M. Traglia,  and  R.W. Dunst.  1990. The yeast  RNA1  gene 
product necessary for RNA processing is located in the cytosol and appar- 
ently excluded from the nucleus. J. Cell BioL 111:309-321. 
Imamoto, N., T. Shimamoto, T. Takao, T. Tachibana, S. Kose, M. Matsubae, T. 
Sekimoto, Y. Shimonishi, and Y. Yoneda. 1995. In vivo evidence for involve- 
ment of a 58 kda component of nuclear pore-targeting  complex in nuclear 
protein import. EMBO (Eur. MoL Biol. Organ.) J. 14:3617-3626. 
Jentsch, S., and S. Schlenker.  1995. Selective protein  degradation:  a journey's 
end within the proteasome. CelL 82:881-884. 
Kirkpatrick,  D., and F. Solomon. 1994. Overexpression  of yeast homologs of 
the mammalian checkpoint gene RCC1 suppresses the class of alpha-tubulin 
mutations that arrest with excess microtubules. Genetics.  137:381-392. 
Koepp, D.M., D.H. Wong, A.H. Corbett, and P.A. Silver. 1996. Dynamic local- 
ization nuclear import receptor and its interactions with transport factors. J. 
Cell BioL 133:1163-1176. 
Kornbluth,  S., M. Dasso, and J. Newport.  1994. Evidence for a dual role for 
TC4 protein in regulating nuclear structure and cell cycle progression. J. Cell 
BioL 125:705-719. 
Kozak, M.  1991. An analysis of vertebrate  mRNA sequences: intimations of 
translational control. Z Cell Biol. 115:887-903. 
Loeb, K.R., and A.L Haas.  1992. The interferon-inducible  15-kDa ubiquitin 
homolog conjugates to intracellular proteins. J. Biol. Chem. 267:7806-7813. 
Lounsbury, K.M., A.L. Beddow, and I.G. Macara. 1994. A family of proteins 
that stabilize the Ran/TC4 GTPase in its GTP-bound conformation. J. BioL 
Chem. 269:11285-11290. 
Mannen, H., H.-M. Tseng, C. Cho, and S.S.-L. Li. 1996. Cloning and expression 
of human homolog HSMT3 to yeast SMT3 suppressor  of MIF2 mutations in 
a centromere protein gene. Biochem. Biophys. Res. Commun. 222:178--180. 
Melchior, F., K. Weber, and V. Gerke.  1993. A functional homologue of the 
RNA1 gene product in Schizosaccharomyces pombe: purification, biochemi- 
cal characterization,  and identification of a leucine-rich repeat  motif. MoL 
Biol. Cell 4:569-581. 
Melchior, F., T. Guan, N. Yokoyama, T. Nishimoto, and L. Gerace. 1995. GTP 
hydrolysis by Ran occurs at the nuclear pore complex in an early step of pro- 
tein import. J. Cell BioL 131:571-581. 
Melchior, F., B. Paschal, J. Evans, and L. Gerace.  1993. Inhibition  of nuclear 
protein  import by nonhydrolyzable analogues of GTP and identification of 
the small GTPase Ran/TC4 as an essential transport factor. J. Cell BioL 123: 
1649-1659. 
Meluh, P.B., and D. Koshland. 1995. Evidence that the MIF2 gene of Saccharo- 
myces cerevisiae encodes a centromere  protein  with homology to the mam- 
malian centromere protein CENP-C. Mol. Biol. Cell. 6:793-807. 
Moore, M.S., and G. Blobel. 1993. The GTP-binding protein Ran/TC4  is re- 
quired for protein import into the nucleus. Nature (Lond.). 365:661-663. 
Moore, M.S., and G. Blobel. 1994. Purification of a Ran-interacting protein that 
is required for protein import into the nucleus. Proc. Natl. Acad. Sci.  USA. 
91:10212-10216. 
Moroianu, J., G. Blobel, and A. Radu. 1995a. Previously identified protein of 
uncertain function is karyopherin alpha and together with karyopherin beta 
docks import  substrate  at nuclear  pore complexes. Proc.  NatL  Acad.  Sci. 
USA. 92:2008-2011. 
Moroianu, J., M. Hijikata, G. Blobel, and A. Radu. 1995b. Mammalian karyo- 
pherin alpha 1 beta and alpha 2 beta heterodimers:  alpha 1 or alpha 2 sub- 
unit binds nuclear localization signal and beta subunit interacts with peptide 
repeat-containing  nucleoporins. Proc. Natl. Acad. Sci.  USA. 92:6532--6536. 
Moroianu, J., G. Blobel, and A. Radu. 1996. Nuclear protein import: Ran-GTP 
dissociates the karyopherin a13 heterodimer  by displacing a from an overlap- 
ping binding site on 13. Proc. Natl. Acad. Sci. USA. 93:7059-7062. 
Nehrbass, U., and G. Blobel. 1996. Role of the nuclear transport factor pl0 in 
nuclear import. Science (Wash. DC). 272:120-122. 
Ohtsubo, M., R. Kai, N. Furuno, T. Sekiguehi, M. Sekiguchi, H. Hayashida, K. 
Kuma, T. Miyata, S. Fukushige, T. Murotsu, et al. 1987. Isolation and charac- 
terization of the active cDNA of the human cell cycle gene (RCC1) involved 
in the regulation of onset of chromosome condensation. Genes Dev. 1:585--593. 
Ohtsubo, M., H. Okazaki, and T. Nishimoto. 1989. The RCC1 protein, a regula- 
tor for the onset of chromosome  condensation  locates in the  nucleus and 
binds to DNA. J. Cell BioL 109:1389-1397. 
Paschal, B.M., and L. Gerace.  1995. Identification  of NTF2, a cytosolic factor 
for nuclear import that interacts with nuclear pore complex protein p62. J. 
Cell BioL 129:925-937. 
Paschal, B.M., C. Delphin, and L. Gerace. 1996. Nucleotide-specific interaction 
of Ran.rl'c4 with nuclear transport factors NTF2 and p97. Proc. Natl. Acad. 
Sci.  USA. 93:7679-7683. 
Radu, A., G. Blobel, and M.S. Moore. 1995. Identification of a protein complex 
that is required for nuclear protein  import and mediates docking of import 
substrate to distinct nucleoporins. Proc. Natl. Acad. Sci.  USA. 92:1769-1773. 
Rexach, M., and G. Blobel. 1995. Protein  import into nuclei: association and 
dissociation reactions  involving transport substrate,  transport factors, and 
nucleoporins. Cell. 83:683-692. 
Roth, A.F., and N.G. Davis. 1996. Ubiquitination  of the yeast a-factor receptor. 
J. Cell BioL 134:661-674. 
Rout,  M.P., and S.R. Wente.  1994. Pores  for thought: nuclear pore proteins. 
Trends Cell BioL 4:357-365. 
Rush, M.G., G. Drivas, and P. D'Eustachio.  1996. The small Nuclear GTPase 
Ran: how much does it run? BioEssays. 18:103-112. 
Sazer, S. 1996. The search for the primary function of the Ran GTPase contin- 
ues. Trends Cell BioL 6:81-85. 
Schlesinger, D.H., G. Goldstein, and H.D. Niall. 1975. The complete amino acid 
of ubiquitin, an adenylate cyclase stimulating polypeptide probably univer- 
sal in living cells. Biochemistry. 14:2214-2218. 
Strous, G.J.,  P.V. Kerkhof,  R.  Govers,  A. Ciechanover,  and  A.L.  Schwartz. 
1996. The ubiquitin  conjugation  system is required  for ligand-induced en- 
docytosis and degradation  of the growth hormone receptor.  EMBO  (Eur. 
MoL BioL Organ.) J. 15:3806-3812. 
Traglia, H.M., N.S. Atkinson, and A.K. Hopper. 1989. Structural and functional 
analyses of Saccharomyces  cerevisiae wild-type and  mutant RNA1  genes. 
MoL Cell. Biol. 9:2989-2999. 
Weis, K., I.W. Mattaj, and A.I. Lamond.  1995. Identification  of hsrpl-a as a 
functional receptor for nuclear localization sequences. Science (Wash. DC). 
268:1049-1053. 
Wilkinson, K.D. 1995. Roles of ubiquitinylation in proteolysis and cellular regu- 
lation. Annu. Rev. Nutr. 15:161-189. 
Wu, J., M.J. Matunis, D. Kraemer, G. Blobel, and E. Coutavas. 1995. Nup358, a 
cytoplasmically exposed nucleoporin  with pepfide  repeats,  ran-gtp binding 
sites, zinc fingers, a cyclophilin a homologous domain, and a leueine-rich re- 
gion. J. BioL Chem. 270:14209-14213. 
Yokoyama, N., N. Hayashi, T. Seki, N. Pante, T. Ohba, K. Nishii, K. Kuma, T. 
Hayashida, T. Miyata, U. Aebi, M. Fukui, and T. Nishimoto. 1995. A giant 
nucleopore protein that binds ran/tc4. Nature (Lond.). 376:184-188. 
The Journal of Cell Biology, Volume 135, 1996  1470 